Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions

Chronic Graft Versus Host Disease Oral

Interventions

DRUG

Tacrolimus

Participants will receive a tacrolimus treatment via toothpaste application twice daily for three months.

Trial Locations (1)

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors

lead

Children's Hospital Medical Center, Cincinnati

OTHER